Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis

Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis

Bibliographic Details
Main Authors:	Gilliam, Brooke E, Chauhan, Anil K, Moore, Terry L
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765710/

Similar Items

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
by: Guseinova, D, et al.
Published: (2008)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
by: Tebo, Anne E, et al.
Published: (2012)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
by: Mohamed Hamooda, et al.
Published: (2016-09-01)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
by: Hamooda, Mohamed, et al.
Published: (2016)

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
by: Vossenaar, Erik R, et al.
Published: (2004)

Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis
by: Gilliam, Brooke E, et al.
Published: (2011)

Presence of anti-cyclic citrullinated peptide antibody isotypes in juvenile idiopathic arthritis synovial fluid indicates autoantibody production at the site of inflammation
by: Gilliam, Brooke E, et al.
Published: (2012)

Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis
by: Gilliam, Brooke E, et al.
Published: (2012)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
by: Al-Shukaili, Ahmed, et al.
Published: (2012)

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
by: Salugina, SO, et al.
Published: (2008)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
by: Gonzalez-Lopez, Laura, et al.
Published: (2014)

Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
by: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Published: (2011)

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis
by: Van Steendam, Katleen, et al.
Published: (2011)

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
by: Dejaco, Christian, et al.
Published: (2006)

Meta-Analysis: Diagnostic Accuracy of Anti-Cyclic Citrullinated Peptide Antibody for Juvenile Idiopathic Arthritis
by: Wang, Yan, et al.
Published: (2015)

Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis
by: Safi, Mohammad-Ayman A., et al.
Published: (2015)

Anti-keratin and anti-cyclic citrullinated peptide autoantibodies in patients with juvenile idiopathic arthritis
by: Vavrinec, J, et al.
Published: (2002)

Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera
by: Trier, Nicole Hartwig, et al.
Published: (2016)

Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens
by: Fernandes-Cerqueira, Cátia, et al.
Published: (2015)

Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
by: Díaz-Toscano, Miriam Lizette, et al.
Published: (2014)

Diagnostic value of different anti-citrullinated peptides antibodies in rheumatoid arthritis
by: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Published: (2011)

Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis
by: Puszczewicz, Mariusz, et al.
Published: (2011)

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis
by: Habets, Kim L.L., et al.
Published: (2015)

Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
by: El-Banna, Hassan, et al.
Published: (2014)

Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
by: Vignesh, Ammapati Paul Pandian, et al.
Published: (2015)

Anti-cyclic citrullinated peptide: its prevalence and clinical significance in a South African cohort with juvenile idiopathic arthritis
by: Mistry, BJ, et al.
Published: (2008)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
by: Abdeen, Suad, et al.
Published: (2011)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
by: Bo, Li, et al.
Published: (2008)

Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies
by: Reed, Evan, et al.
Published: (2016)

Tolerogenic citrullinated peptide for arthritis
by: Gertel, Smadar, et al.
Published: (2015)

Onset of polyarticular juvenile idiopathic arthritis with both anti-cyclic citrullinated peptide antibodies and rheumatoid factor in a 3-year-old girl
by: Yasui, Kozo, et al.
Published: (2012)

Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis
by: Turunen, Sanna, et al.
Published: (2013)

Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays
by: Vander Cruyssen, Bert, et al.
Published: (2006)

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis
by: Avdeeva, A. S., et al.
Published: (2014)

Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis
by: Lindenberg, Luisa, et al.
Published: (2015)

Early Diagnosing and Treatment of Rheumatoid Arthritis, Benefits of Anti-Citrullinated Peptides Examination
by: Belakova Gabriela, et al.
Published: (2017-08-01)

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
by: van Damme, N, et al.
Published: (2002)

Anti-Cyclic Citrullinated Peptide Antibodies and Joint Involvement in Behçet's Disease
by: Cho, Sung Bin, et al.
Published: (2012)

Contribution of Peptide Backbone to Anti-Citrullinated Peptide Antibody Reactivity
by: Trier, Nicole Hartwig, et al.
Published: (2015)

Development of synthetic anti-cyclic citrullinated peptide antibody and its arthritogenic role
by: Kim, Youngkyun, et al.
Published: (2015)